Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage.
| Drug | Drug Description |
|---|---|
| Botulinum toxin type B | A purified form of botulinum toxin type B used to block acetylcholine release in the treatment of cervical dystonia and sialorrhea. |
| Botulinum toxin type A | A purified form of botulinum toxin type A used to block acetylcholine release in the treatment of chronic sialorrhea, muscle spasticity, and dystonia, as well as in cosmetic applications. |
| Nicotine | A stimulatory alkaloid found in tobacco products that is often used for the relief of nicotine withdrawal symptoms and as an aid to smoking cessation. |
| Cevimeline | A muscarinic agonist with parasympathomimetic activities that is used for the symptomatic treatment of dry mouth in patients with Sjögren's Syndrome. |
| Trospium | An antimuscarinic agent used to treat the symptoms of overactive bladder (OAB). |
| Oxyphenonium | For the treatment of visceral spasms |
| Benzatropine | An anticholinergic drug used to treat Parkinson's disease (PD) and extrapyramidal symptoms, except tardive dyskinesia. |
| Ipratropium | An anticholinergic drug used in the control of symptoms related to bronchospasm in chronic obstructive pulmonary disease (COPD). |
| Trihexyphenidyl | An antispasmodic drug used as an adjunct drug in the management of parkinsonism and as a treatment for extrapyramidal symptoms caused by drugs affecting the central nervous system (CNS). |
| Tacrine | An anticholinesterase drug used for the management of Alzheimer's disease symptoms. |
| Procyclidine | An antispasmodic drug used to treat parkinsonism of various types and in the treatment of extrapyramidal symptoms. |
| Profenamine | An antidyskinetic phenothiazine used to treat the symptoms of Parkinson's disease. |
| Carbamoylcholine | A direct acting miotic agent administered ophthalmically to decrease intraocular pressure after cataract surgery, and to induce miosis during surgery. |
| Hyoscyamine | An anticholinergic indicated to treat functional gastrointestinal disorders, biliary and renal colic, and acute rhinitis. |
| Gallamine triethiodide | A nondepolarizing nerve blocker used in addition to anesthesia to cause skeletal muscle relaxation. |
| Darifenacin | An M3 muscarinic receptor blocker used to treat urinary incontinence. |
| Anisotropine methylbromide | For use in conjunction with antacids or histamine H2-receptor antagonists in the treatment of peptic ulcer, to reduce further gastric acid secretion and delay gastric emptying. |
| Pyridostigmine | A cholinesterase inhibitor used for symptomatic treatment of myasthenia gravis and congenital myasthenic syndromes and to reverse neuromuscular blockade by nondepolarizing muscle relaxants. |
| Atropine | A muscarinic antagonist used to treat poisoning by muscarinic agents, including organophosphates and other drugs. |
| Mecamylamine | A nicotine antagonist used to treat moderate to severe essential hypertension and uncomplicated malignant hypertension. |
| Pirenzepine | An antimuscarinic agent used to treat peptic ulcers, gastric ulcers, and duodenal ulcers. |
| Galantamine | A cholinesterase inhibitor used to manage mild to moderate dementia associated with Alzheimer's Disease. |
| Isoflurophate | For use in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia. |
| Atracurium besylate | A non-depolarizing neuromuscular blocker used to facilitate endotracheal intubation and relax skeletal muscles during surgery. |
| Pralidoxime | A cholinesterase reactivator used to treat organophosphate poisoning. |
| Scopolamine | A belladonna alkaloid with anticholinergic effects indicated for the treatment of nausea and vomiting associated with motion sickness and postoperative nausea and vomiting (PONV). |
| Malathion | A parasympathomimetic organophosphate used to treat head lice. |
| Propantheline | An antimuscarinic agent used to treat urinary incontinence, hyperhidrosis, as well as cramps and spasms of the stomach, intestines, and bladder. |
| Dicyclomine | An antimuscarinic agent used to treat IBS. |
| Tropicamide | A muscarinic receptor antagonist used to induce mydriasis and cycloplegia for diagnostic procedures. |
| Biperiden | A muscarinic receptor antagonist used to treat parkinsonism and control extrapyramidal side effects of neuroleptic drugs. |
| Donepezil | An acetylcholinesterase inhibitor used to treat the behavioral and cognitive effects of Alzheimer's Disease and other types of dementia. |
| Quinidine | A medication used to restore normal sinus rhythm, treat atrial fibrillation and flutter, and treat ventricular arrhythmias. |
| Methantheline | For the treatment of peptic ulcer disease, irritable bowel syndrome, pancreatitis, gastritis, biliary dyskinesia, pylorosplasm, and reflex neurogenic bladder in children. |
| Demecarium | For the topical treatment of chronic open-angle glaucoma. |
| Desloratadine | A second generation tricyclic antihistamine used to treat seasonal and non seasonal allergic rhinitis, pruritus, and urticaria. |
| Cyclopentolate | An anticholinergic used to cause mydriasis and cycloplegia for diagnostic testing. |
| Physostigmine | A cholinesterase inhibitor used to treat glaucoma and anticholinergic toxicity. |
| Glycopyrronium | An anticholinergic agent used to treat hyperhidrosis, severe drooling, COPD, used with other medications to treat ulcers, and used in anesthesia. |
| Rivastigmine | A cholinesterase inhibitor used to treat mild to moderate dementia in Alzheimer's and Parkinson's. |
| Edrophonium | A cholinesterase inhibitor used to diagnose and evaluate myasthenia gravis. |
| Bethanechol | A muscarinic agonist used to treat postoperative and postpartum nonobstructive functional urinary retention and neurogenic atony of the bladder with retention. |
| Tolterodine | A muscarinic receptor antagonist used to treat overactive bladder with urinary incontinence, urgency, and frequency. |
| Echothiophate | An acetylcholinesterase inhibitor used in ophthalmic preparations to increase the drainage of intraocular fluid; most commonly used for the treatment of glaucoma. |
| Pilocarpine | A muscarinic agonist used to treat dry mouth and various ophthalmic conditions, such as presbyopia, increased intraocular pressure, and angle-closure glaucoma. |
| Pentolinium | Used to produce controlled hypotension during surgical procedures and in hypertensive crises. |
| Trimethaphan | For the controlled reduction of blood pressure during surgery and in the treatment of hypertensive emergencies. |
| Ambenonium | A cholinesterase inhibitor that targets both muscarinic and nicotinic receptors indicated for the treatment of myasthenia gravis. |
| Orphenadrine | A muscarinic antagonist used as an adjunct for the symptomatic relief of musculoskeletal pain and discomfort. |
| Tubocurarine | Tubocurarine is a non-depolarizing neuromuscular blocking agent and the first identified curare alkaloid. Curare is one of the names used to describe plant-derived poisons used by indigenous South Americans to. |
| Varenicline | A partial agonist at nicotinic acetylcholine receptors used as an aid in smoking cessation. |
| Pancuronium | A neuromuscular blocker used as an adjunct to general anesthesia to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. |
| Pipecuronium | A nondepolarizing neuromuscular blocking agent used to relax muscles during anesthesia and surgical procedures. |
| Vecuronium | A nondepolarizing neuromuscular blocking agent used to relax muscles or as an adjunct in general anesthesia during surgical procedures. |
| Neostigmine | A cholinesterase inhibitor used in the symptomatic treatment of myasthenia gravis by improving muscle tone. |
| Tiotropium | A long-acting bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). |
| Solifenacin | A muscarinic antagonist with antispasmodic properties used to treat urge urinary incontinence, urgency, and urinary frequency associated with an overactive bladder. |
| 1,10-Phenanthroline | Not Available |
| Acetylcholine | A parasympathomimetic neurotransmitter used to induce miosis of the iris in seconds after delivery of the lens in cataract surgery, in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required. |
| Arecoline | An alkaloid obtained from the betel nut (Areca catechu), fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the. |
| Huperzine A | Investigated for use/treatment in alzheimer's disease. |
| Lobeline | Investigated for use/treatment in addictions. |
| GTS-21 | Investigated for use/treatment in alzheimer's disease and schizophrenia and schizoaffective disorders. |
| Fesoterodine | An antimuscarinic agent used in the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. |
| Methacholine | A parasympathomimetic bronchoconstrictor used to diagnose bronchial hyperreactivity in subjects who do not have clinically apparent asthma. |
| Epibatidine | Not Available |
| Hexamethonium | A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been. |
| Dexetimide | A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the (-)-enantimorph of dexetimide. |
| Chlorphenoxamine | An antihistamine used as an antipruritic. |
| Benactyzine | Benactyzine is an anticholinergic drug used as an antidepressant in the treatment of depression and associated anxiety. Benactyzine is no longer widely used in medicine, although it is still a. |
| Butylscopolamine | An antispasmodic and anticholinergic agent used for the symptomatic treatment of abdominal cramping and pain. |
| Coumaphos | This drug is a fat-soluble phosphorothioate agent that kills both insects and mites. It is non-volatile in nature and is well known by a variety of names as such a. |
| Dichlorvos | Dichlorvos or 2,2-dichlorovinyl dimethyl phosphate is a drug of the organophosphate class, frequently used as an insecticide for the control of indoor pests and for the protection of stored products. |
| Fenthion | Fenthion is an organothiophosphate drug used as an insecticide, avicide, and acaricide. Its mode of action is explained by cholinesterase enzyme inhibition, which is similar to other organophosphates. Fenthion is. |
| Imidacloprid | Imidacloprid is a neonicotinoid, which is a class of neuro-active insecticides modeled after nicotine. Imidacloprid is a patented chemical, Imidacloprid is manufactured by Bayer Cropscience (part of Bayer AG) and. |
| Metrifonate | Metrifonate or trichlorfon is an irreversible organophosphate acetylcholinesterase inhibitor. It is a prodrug which is activated non-enzymatically into 2,2-dichlorovinyl dimethyl phosphate. |
| Propiverine | An antimuscarinic agent used to treat urinary incontinence or increased urinary frequency or urgency. |
| Methanesulfonyl Fluoride | Methanesulfonyl Fluoride has been used in trials studying the treatment of Safety. |
| Atracurium | A neuromuscular blocker indicated to relax muscles during mechanical ventilation under general anesthesia or intubation. |
| Phenglutarimide | Not Annotated |
| Paraoxon | Not Annotated |
| Otilonium | A spasmolytic medication used to treat irritable bowel syndrome (IBS). |
| Emepronium | Not Annotated |
| Gallamine | Not Annotated |
| Bornaprine | An anticholinergic drug indicated in the treatment of hyperhidrosis, dyskinesia, akathisia, parkinsonism, and Parkinson's disease. |
| Alcuronium | A non-depolarizing skeletal muscle relaxant similar to tubocurarine. It is used as an anesthesia adjuvant. |
| Distigmine | A cholinesterase inhibitor indicated in the treatment of neurogenic bladder dysfunction or myasthenia gravis. |
| Obidoxime | Not Annotated |
| Mivacurium | A short-acting non-depolarizing neuromuscular blocking agent used to induce anesthesia during intubation and promote skeletal muscle relaxation during surgery or mechanical ventilation. |
| Xanomeline | Xanomeline is under investigation in clinical trial NCT02831231 (Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium). |
| Azatadine | An H1 receptor antagonist used to treat perennial and allergic rhinitis as well as eustachian tube congestion. |
| Meclizine | A histamine H1 antagonist used to treat nausea, vomiting, and dizziness associated with motion sickness. |
| Hexafluronium | Used as an adjunct with succinylcholine (or suxamethonium chloride) to prolong muscle relaxation and to prevent succinylcholine-induced muscle fasciculations. |
| Phenserine | For the treatment of Alzheimer's disease (AD). |
| NGX267 | Investigated for use/treatment in alzheimer's disease and schizophrenia and schizoaffective disorders. |
| Acotiamide | Acotiamide has been used in trials studying the treatment of Dyspepsia and Functional Dyspepsia. |
| Posiphen | Posiphen is under investigation in clinical trial NCT02925650 (Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease). |
| Carbaryl | A medication used in shampoo to remove lice. |
| Homidium | Homidium is a group II compound with trypanocidal effects. |
| TAK-071 | TAK-071 is under investigation in clinical trial NCT04334317 (A Study of TAK-071 in People With Parkinson Disease). |
| Chlorisondamine | Not Annotated |
Drugs & Drug Targets
| Drug | Target | Type |
|---|---|---|
| Botulinum toxin type B | Vesicle-associated membrane protein 1 | target |
| Botulinum toxin type B | Vesicle-associated membrane protein 2 | target |
| Botulinum toxin type B | Synaptotagmin-2 | target |
| Botulinum toxin type A | Synaptosomal-associated protein 25 | target |
| Botulinum toxin type A | Rho-related GTP-binding protein RhoB | target |
| Botulinum toxin type A | Serum albumin | carrier |
| Nicotine | Neuronal acetylcholine receptor subunit alpha-2 | target |
| Nicotine | Neuronal acetylcholine receptor subunit beta-2 | target |
| Nicotine | Neuronal acetylcholine receptor subunit alpha-7 | target |
| Nicotine | Neuronal acetylcholine receptor subunit alpha-4 | target |
| Nicotine | Neuronal acetylcholine receptor subunit alpha-10 | target |
| Nicotine | Neuronal acetylcholine receptor subunit alpha-9 | target |
| Nicotine | Cytochrome P450 2A6 | enzyme |
| Nicotine | Cytochrome P450 2E1 | enzyme |
| Nicotine | Cytochrome P450 2A13 | enzyme |
| Nicotine | Cytochrome P450 2B6 | enzyme |
| Nicotine | Neuronal acetylcholine receptor subunit beta-4 | target |
| Nicotine | Neuronal acetylcholine receptor subunit alpha-3 | target |
| Nicotine | Neuronal acetylcholine receptor subunit alpha-5 | target |
| Nicotine | Neuronal acetylcholine receptor subunit alpha-6 | target |
| Nicotine | Neuronal acetylcholine receptor subunit beta-3 | target |
| Nicotine | Solute carrier family 22 member 2 | transporter |
| Nicotine | Solute carrier family 22 member 1 | transporter |
| Nicotine | Solute carrier family 22 member 3 | transporter |
| Nicotine | Solute carrier family 22 member 5 | transporter |
| Nicotine | Solute carrier family 22 member 4 | transporter |
| Nicotine | Cytochrome P450 1A1 | enzyme |
| Nicotine | Cytochrome P450 1A2 | enzyme |
| Nicotine | Cytochrome P450 2C19 | enzyme |
| Nicotine | Cytochrome P450 2C8 | enzyme |
| Nicotine | Cytochrome P450 2C9 | enzyme |
| Nicotine | Cytochrome P450 2D6 | enzyme |
| Nicotine | Cytochrome P450 3A4 | enzyme |
| Nicotine | Amine oxidase [flavin-containing] A | enzyme |
| Nicotine | Amine oxidase [flavin-containing] B | enzyme |
| Nicotine | Cytochrome P450 19A1 | target |
| Nicotine | Choline O-acetyltransferase | target |
| Cevimeline | Muscarinic acetylcholine receptor M1 | target |
| Cevimeline | Muscarinic acetylcholine receptor M3 | target |
| Cevimeline | Cytochrome P450 3A4 | enzyme |
| Cevimeline | Cytochrome P450 2D6 | enzyme |
| Cevimeline | Dimethylaniline monooxygenase [N-oxide-forming] 1 | enzyme |
| Trospium | Muscarinic acetylcholine receptor M1 | target |
| Trospium | Cytochrome P450 2D6 | enzyme |
| Trospium | Muscarinic acetylcholine receptor M3 | target |
| Trospium | Muscarinic acetylcholine receptor M5 | target |
| Oxyphenonium | Muscarinic acetylcholine receptor M1 | target |
| Benzatropine | Muscarinic acetylcholine receptor M1 | target |
| Benzatropine | Sodium-dependent dopamine transporter | target |
| Benzatropine | Histamine H1 receptor | target |
| Benzatropine | Serum albumin | carrier |
| Benzatropine | Sodium-dependent serotonin transporter | target |
| Benzatropine | Sodium-dependent noradrenaline transporter | target |
| Ipratropium | Muscarinic acetylcholine receptor M1 | target |
| Ipratropium | Muscarinic acetylcholine receptor M2 | target |
| Ipratropium | Muscarinic acetylcholine receptor M3 | target |
| Ipratropium | Solute carrier family 22 member 5 | transporter |
| Ipratropium | Solute carrier family 22 member 4 | transporter |
| Ipratropium | Serum albumin | carrier |
| Ipratropium | alpha1-acid glycoprotein | carrier |
| Trihexyphenidyl | Muscarinic acetylcholine receptor M1 | target |
| Trihexyphenidyl | Muscarinic acetylcholine receptor M2 | target |
| Trihexyphenidyl | Muscarinic acetylcholine receptor M3 | target |
| Trihexyphenidyl | Muscarinic acetylcholine receptor M4 | target |
| Trihexyphenidyl | Muscarinic acetylcholine receptor M5 | target |
| Trihexyphenidyl | Serum albumin | carrier |
| Trihexyphenidyl | Beta-3 adrenergic receptor | target |
| Tacrine | Acetylcholinesterase | target |
| Tacrine | Cytochrome P450 1A2 | enzyme |
| Tacrine | Cholinesterase | target |
| Tacrine | P-glycoprotein 1 | transporter |
| Tacrine | Liver carboxylesterase 1 | target |
| Procyclidine | Muscarinic acetylcholine receptor M1 | target |
| Procyclidine | Muscarinic acetylcholine receptor M2 | target |
| Procyclidine | Muscarinic acetylcholine receptor M4 | target |
| Procyclidine | Muscarinic acetylcholine receptor M3 | target |
| Procyclidine | Muscarinic acetylcholine receptor M5 | target |
| Profenamine | Glutamate receptor ionotropic, NMDA 3A | target |
| Profenamine | Muscarinic acetylcholine receptor M1 | target |
| Profenamine | Cholinesterase | enzyme |
| Profenamine | Muscarinic acetylcholine receptor M2 | target |
| Profenamine | Histamine H1 receptor | target |
| Carbamoylcholine | Muscarinic acetylcholine receptor M1 | target |
| Carbamoylcholine | Muscarinic acetylcholine receptor M2 | target |
| Carbamoylcholine | Neuronal acetylcholine receptor subunit alpha-2 | target |
| Carbamoylcholine | Cytosolic phospholipase A2 | enzyme |
| Carbamoylcholine | Muscarinic acetylcholine receptor M3 | target |
| Carbamoylcholine | Muscarinic acetylcholine receptor M4 | target |
| Carbamoylcholine | Acetylcholinesterase | enzyme |
| Hyoscyamine | Muscarinic acetylcholine receptor M1 | target |
| Hyoscyamine | Muscarinic acetylcholine receptor M2 | target |
| Hyoscyamine | Muscarinic acetylcholine receptor M3 | target |
| Hyoscyamine | Muscarinic acetylcholine receptor M4 | target |
| Hyoscyamine | Adenylate cyclase type 1 | target |
| Hyoscyamine | Muscarinic acetylcholine receptor M5 | target |
| Gallamine triethiodide | Neuronal acetylcholine receptor subunit alpha-2 | target |
| Gallamine triethiodide | Muscarinic acetylcholine receptor M2 | target |
| Gallamine triethiodide | Acetylcholinesterase | target |
| Gallamine triethiodide | Muscarinic acetylcholine receptor M1 | target |
| Gallamine triethiodide | Muscarinic acetylcholine receptor M5 | target |
| Darifenacin | Muscarinic acetylcholine receptor M3 | target |
| Darifenacin | Cytochrome P450 3A4 | enzyme |
| Darifenacin | Cytochrome P450 2D6 | enzyme |
| Darifenacin | Muscarinic acetylcholine receptor M1 | target |
| Darifenacin | Muscarinic acetylcholine receptor M2 | target |
| Darifenacin | Muscarinic acetylcholine receptor M4 | target |
| Darifenacin | Muscarinic acetylcholine receptor M5 | target |
| Anisotropine methylbromide | Muscarinic acetylcholine receptor M1 | target |
| Anisotropine methylbromide | Muscarinic acetylcholine receptor M2 | target |
| Anisotropine methylbromide | Muscarinic acetylcholine receptor M3 | target |
| Anisotropine methylbromide | Muscarinic acetylcholine receptor M5 | target |
| Pyridostigmine | Acetylcholinesterase | target |
| Pyridostigmine | Cholinesterase | target |
| Pyridostigmine | Acetylcholinesterase | enzyme |
| Pyridostigmine | Cholinesterase | enzyme |
| Pyridostigmine | Cytochrome P450 3A4 | enzyme |
| Pyridostigmine | Coagulation factor X | target |
| Atropine | Muscarinic acetylcholine receptor M2 | target |
| Atropine | Muscarinic acetylcholine receptor M1 | target |
| Atropine | Muscarinic acetylcholine receptor M4 | target |
| Atropine | Muscarinic acetylcholine receptor M5 | target |
| Atropine | Muscarinic acetylcholine receptor M3 | target |
| Atropine | Glycine receptor subunit alpha-1 | target |
| Atropine | Neuronal acetylcholine receptor subunit alpha-4 | target |
| Atropine | Neuronal acetylcholine receptor subunit beta-2 | target |
| Atropine | Bile salt export pump | transporter |
| Atropine | Alpha-1-acid glycoprotein 1 | carrier |
| Mecamylamine | Neuronal acetylcholine receptor subunit alpha-2 | target |
| Mecamylamine | Neuronal acetylcholine receptor subunit alpha-7 | target |
| Mecamylamine | Neuronal acetylcholine receptor subunit alpha-4 | target |
| Mecamylamine | Neuronal acetylcholine receptor subunit beta-2 | target |
| Pirenzepine | Muscarinic acetylcholine receptor M1 | target |
| Galantamine | Acetylcholinesterase | target |
| Galantamine | Cytochrome P450 3A4 | enzyme |
| Galantamine | Cytochrome P450 2D6 | enzyme |
| Galantamine | Cholinesterase | target |
| Galantamine | P-glycoprotein 1 | transporter |
| Galantamine | Neuronal acetylcholine receptor subunit alpha-7 | target |
| Galantamine | Muscle nicotinic acetylcholine receptor | target |
| Isoflurophate | Cholinesterase | target |
| Isoflurophate | Acetylcholinesterase | target |
| Isoflurophate | Cholinesterase | enzyme |
| Isoflurophate | Serum albumin | carrier |
| Isoflurophate | Serotransferrin | target |
| Atracurium besylate | Neuronal acetylcholine receptor subunit alpha-2 | target |
| Pralidoxime | Acetylcholinesterase | target |
| Pralidoxime | Cholinesterase | target |
| Scopolamine | Muscarinic acetylcholine receptor M1 | target |
| Scopolamine | Sucrase-isomaltase, intestinal | target |
| Scopolamine | Muscarinic acetylcholine receptor M2 | target |
| Scopolamine | Muscarinic acetylcholine receptor M3 | target |
| Scopolamine | Muscarinic acetylcholine receptor M4 | target |
| Scopolamine | Muscarinic acetylcholine receptor M5 | target |
| Scopolamine | Neuronal acetylcholine receptor subunit alpha-4 | target |
| Scopolamine | Neuronal acetylcholine receptor subunit beta-2 | target |
| Scopolamine | Cytochrome P450 3A4 | enzyme |
| Malathion | Cholinesterase | target |
| Malathion | Cytochrome P450 1A2 | enzyme |
| Malathion | Cytochrome P450 2B6 | enzyme |
| Malathion | Acetylcholinesterase | target |
| Propantheline | Muscarinic acetylcholine receptor M1 | target |
| Dicyclomine | Muscarinic acetylcholine receptor M1 | target |
| Dicyclomine | Muscarinic acetylcholine receptor M2 | target |
| Dicyclomine | Muscarinic acetylcholine receptor M3 | target |
| Tropicamide | Muscarinic acetylcholine receptor M4 | target |
| Tropicamide | Muscarinic acetylcholine receptor M1 | target |
| Tropicamide | Muscarinic acetylcholine receptor M2 | target |
| Tropicamide | Muscarinic acetylcholine receptor M3 | target |
| Biperiden | Muscarinic acetylcholine receptor M1 | target |
| Biperiden | Cytochrome P450 2D6 | enzyme |
| Donepezil | Acetylcholinesterase | target |
| Donepezil | 5-hydroxytryptamine receptor 2A | target |
| Donepezil | Cytochrome P450 3A4 | enzyme |
| Donepezil | Cytochrome P450 2D6 | enzyme |
| Donepezil | Cytochrome P450 2C9 | enzyme |
| Donepezil | Cholinesterase | target |
| Donepezil | Nitric oxide synthase, brain | target |
| Donepezil | Tumor necrosis factor-inducible gene 6 protein | target |
| Donepezil | Interleukin-1 beta | target |
| Donepezil | Nuclear factor NF-kappa-B | target |
| Donepezil | ATP-binding cassette sub-family G member 2 | transporter |
| Donepezil | NMDA receptor | target |
| Quinidine | Sodium channel protein type 5 subunit alpha | target |
| Quinidine | Alpha-1-acid glycoprotein 1 | carrier |
| Quinidine | Potassium voltage-gated channel subfamily H member 2 | target |
| Quinidine | Potassium channel subfamily K member 1 | target |
| Quinidine | Potassium channel subfamily K member 6 | target |
| Quinidine | Cytochrome P450 1A2 | enzyme |
| Quinidine | Cytochrome P450 2E1 | enzyme |
| Quinidine | Cytochrome P450 1A1 | enzyme |
| Quinidine | Cytochrome P450 2D6 | enzyme |
| Quinidine | Cytochrome P450 3A4 | enzyme |
| Quinidine | Cytochrome P450 3A7 | enzyme |
| Quinidine | Solute carrier family 22 member 2 | transporter |
| Quinidine | Solute carrier family 22 member 1 | transporter |
| Quinidine | Solute carrier family 22 member 5 | transporter |
| Quinidine | P-glycoprotein 1 | transporter |
| Quinidine | Solute carrier organic anion transporter family member 1A2 | transporter |
| Quinidine | Solute carrier family 22 member 8 | transporter |
| Quinidine | Canalicular multispecific organic anion transporter 1 | transporter |
| Quinidine | Solute carrier family 22 member 4 | transporter |
| Quinidine | Solute carrier organic anion transporter family member 1B1 | transporter |
| Quinidine | Cytochrome P450 2B6 | enzyme |
| Quinidine | Cytochrome P450 2C9 | enzyme |
| Quinidine | Alpha-1A adrenergic receptor | target |
| Quinidine | Alpha-1B adrenergic receptor | target |
| Quinidine | Alpha-1D adrenergic receptor | target |
| Quinidine | Bile salt export pump | transporter |
| Quinidine | Cytochrome P450 2C8 | enzyme |
| Quinidine | Serum albumin | carrier |
| Methantheline | Muscarinic acetylcholine receptor M1 | target |
| Methantheline | Histamine H2 receptor | target |
| Methantheline | Muscarinic acetylcholine receptor M2 | target |
| Methantheline | Muscarinic acetylcholine receptor M3 | target |
| Methantheline | Muscarinic acetylcholine receptor M4 | target |
| Methantheline | Muscarinic acetylcholine receptor M5 | target |
| Methantheline | Acetylcholinesterase | enzyme |
| Demecarium | Acetylcholinesterase | target |
| Demecarium | Cholinesterase | target |
| Desloratadine | Histamine H1 receptor | target |
| Desloratadine | P-glycoprotein 1 | transporter |
| Cyclopentolate | Muscarinic acetylcholine receptor M1 | target |
| Cyclopentolate | Cholinesterase | enzyme |
| Cyclopentolate | Muscarinic acetylcholine receptor M5 | target |
| Physostigmine | Acetylcholinesterase | target |
| Physostigmine | Neuronal acetylcholine receptor subunit alpha-4 | target |
| Physostigmine | Neuronal acetylcholine receptor subunit beta-2 | target |
| Glycopyrronium | Muscarinic acetylcholine receptor M1 | target |
| Glycopyrronium | Muscarinic acetylcholine receptor M3 | target |
| Glycopyrronium | Muscarinic acetylcholine receptor M2 | target |
| Glycopyrronium | Cytochrome P450 2D6 | enzyme |
| Glycopyrronium | Cytochrome P450 1A2 | enzyme |
| Glycopyrronium | Cytochrome P450 2B6 | enzyme |
| Glycopyrronium | Cytochrome P450 2C9 | enzyme |
| Glycopyrronium | Cytochrome P450 2C18 | enzyme |
| Glycopyrronium | Cytochrome P450 2C19 | enzyme |
| Glycopyrronium | Cytochrome P450 3A4 | enzyme |
| Glycopyrronium | Solute carrier family 22 member 2 | transporter |
| Glycopyrronium | Multidrug and toxin extrusion protein 1 | transporter |
| Glycopyrronium | Muscarinic acetylcholine receptor M4 | target |
| Glycopyrronium | Muscarinic acetylcholine receptor M5 | target |
| Glycopyrronium | Serum albumin | carrier |
| Glycopyrronium | alpha1-acid glycoprotein | carrier |
| Rivastigmine | Acetylcholinesterase | target |
| Rivastigmine | Cholinesterase | target |
| Edrophonium | Acetylcholinesterase | target |
| Edrophonium | Cholinesterase | target |
| Bethanechol | Muscarinic acetylcholine receptor M2 | target |
| Bethanechol | Muscarinic acetylcholine receptor M1 | target |
| Bethanechol | Muscarinic acetylcholine receptor M3 | target |
| Bethanechol | Muscarinic acetylcholine receptor M4 | target |
| Bethanechol | Muscarinic acetylcholine receptor M5 | target |
| Tolterodine | Muscarinic acetylcholine receptor M1 | target |
| Tolterodine | Muscarinic acetylcholine receptor M2 | target |
| Tolterodine | Muscarinic acetylcholine receptor M3 | target |
| Tolterodine | Cytochrome P450 2D6 | enzyme |
| Tolterodine | Cytochrome P450 3A4 | enzyme |
| Tolterodine | Cytochrome P450 2C9 | enzyme |
| Tolterodine | Cytochrome P450 2C19 | enzyme |
| Tolterodine | Muscarinic acetylcholine receptor M4 | target |
| Tolterodine | Muscarinic acetylcholine receptor M5 | target |
| Echothiophate | Cholinesterase | target |
| Echothiophate | Serum albumin | carrier |
| Echothiophate | Acetylcholinesterase | target |
| Pilocarpine | Muscarinic acetylcholine receptor M1 | target |
| Pilocarpine | Muscarinic acetylcholine receptor M2 | target |
| Pilocarpine | Cytochrome P450 2A6 | enzyme |
| Pilocarpine | Muscarinic acetylcholine receptor M3 | target |
| Pilocarpine | Cytochrome P450 3A4 | enzyme |
| Pilocarpine | Muscarinic acetylcholine receptor M4 | target |
| Pilocarpine | Muscarinic acetylcholine receptor M5 | target |
| Pilocarpine | Serum paraoxonase/arylesterase 1 | enzyme |
| Pentolinium | Neuronal acetylcholine receptor subunit alpha-10 | target |
| Pentolinium | Neuronal acetylcholine receptor subunit alpha-3 | target |
| Pentolinium | Neuronal acetylcholine receptor subunit beta-4 | target |
| Pentolinium | Neuronal acetylcholine receptor subunit alpha-4 | target |
| Trimethaphan | Neuronal acetylcholine receptor subunit alpha-10 | target |
| Trimethaphan | Cholinesterase | enzyme |
| Trimethaphan | Neuronal acetylcholine receptor subunit alpha-4 | target |
| Ambenonium | Acetylcholinesterase | target |
| Ambenonium | Cholinesterase | enzyme |
| Orphenadrine | Glutamate receptor ionotropic, NMDA 1 | target |
| Orphenadrine | Glutamate receptor ionotropic, NMDA 2D | target |
| Orphenadrine | Glutamate receptor ionotropic, NMDA 3B | target |
| Orphenadrine | Glutamate receptor ionotropic, NMDA 3A | target |
| Orphenadrine | Histamine H1 receptor | target |
| Orphenadrine | Cytochrome P450 2B6 | enzyme |
| Orphenadrine | Cytochrome P450 2E1 | enzyme |
| Orphenadrine | Cytochrome P450 3A4 | enzyme |
| Orphenadrine | Sodium-dependent noradrenaline transporter | target |
| Orphenadrine | Sodium channel protein type 10 subunit alpha | target |
| Orphenadrine | Cytochrome P450 1A2 | enzyme |
| Orphenadrine | Cytochrome P450 2D6 | enzyme |
| Orphenadrine | Serum albumin | carrier |
| Tubocurarine | Neuronal acetylcholine receptor subunit alpha-2 | target |
| Tubocurarine | Acetylcholinesterase | target |
| Tubocurarine | 5-hydroxytryptamine receptor 3A | target |
| Tubocurarine | Solute carrier family 22 member 1 | transporter |
| Tubocurarine | Solute carrier family 22 member 2 | transporter |
| Tubocurarine | Neuronal acetylcholine receptor subunit alpha-7 | target |
| Tubocurarine | Cholinesterase | enzyme |
| Varenicline | Neuronal acetylcholine receptor subunit alpha-4 | target |
| Varenicline | Neuronal acetylcholine receptor subunit alpha-7 | target |
| Varenicline | Neuronal acetylcholine receptor subunit alpha-3 | target |
| Varenicline | Neuronal acetylcholine receptor subunit alpha-6 | target |
| Varenicline | Neuronal acetylcholine receptor subunit beta-2 | target |
| Varenicline | Solute carrier family 22 member 2 | transporter |
| Pancuronium | Neuronal acetylcholine receptor subunit alpha-2 | target |
| Pancuronium | Cholinesterase | enzyme |
| Pancuronium | Muscarinic acetylcholine receptor M2 | target |
| Pancuronium | Muscarinic acetylcholine receptor M3 | target |
| Pancuronium | Solute carrier family 22 member 1 | transporter |
| Pancuronium | Solute carrier family 22 member 2 | transporter |
| Pipecuronium | Neuronal acetylcholine receptor subunit alpha-2 | target |
| Pipecuronium | Muscarinic acetylcholine receptor M2 | target |
| Pipecuronium | Muscarinic acetylcholine receptor M3 | target |
| Pipecuronium | Cholinesterase | enzyme |
| Vecuronium | P-glycoprotein 1 | transporter |
| Vecuronium | Neuronal acetylcholine receptor subunit alpha-2 | target |
| Neostigmine | Acetylcholinesterase | target |
| Neostigmine | Cholinesterase | enzyme |
| Tiotropium | Muscarinic acetylcholine receptor M3 | target |
| Tiotropium | Cytochrome P450 2D6 | enzyme |
| Tiotropium | Cytochrome P450 3A4 | enzyme |
| Tiotropium | Muscarinic acetylcholine receptor M1 | target |
| Tiotropium | Muscarinic acetylcholine receptor M2 | target |
| Tiotropium | Solute carrier family 22 member 5 | transporter |
| Tiotropium | Solute carrier family 22 member 4 | transporter |
| Tiotropium | Muscarinic acetylcholine receptor M4 | target |
| Tiotropium | Muscarinic acetylcholine receptor M5 | target |
| Solifenacin | Muscarinic acetylcholine receptor M3 | target |
| Solifenacin | Muscarinic acetylcholine receptor M1 | target |
| Solifenacin | Cytochrome P450 3A4 | enzyme |
| Solifenacin | Muscarinic acetylcholine receptor M2 | target |
| Solifenacin | Muscarinic acetylcholine receptor M4 | target |
| Solifenacin | Muscarinic acetylcholine receptor M5 | target |
| Solifenacin | alpha1-acid glycoprotein | carrier |
| Solifenacin | Cytochrome P450 1A1 | enzyme |
| Solifenacin | Cytochrome P450 2D6 | enzyme |
| 1,10-Phenanthroline | Methyl-accepting chemotaxis protein II | target |
| 1,10-Phenanthroline | Metallo-beta-lactamase L1 | target |
| Acetylcholine | Solute carrier family 22 member 5 | transporter |
| Acetylcholine | Solute carrier family 22 member 1 | transporter |
| Acetylcholine | Muscarinic acetylcholine receptor M1 | target |
| Acetylcholine | Muscarinic acetylcholine receptor M2 | target |
| Acetylcholine | Muscarinic acetylcholine receptor M3 | target |
| Acetylcholine | Muscarinic acetylcholine receptor M4 | target |
| Acetylcholine | Neuronal acetylcholine receptor subunit alpha-7 | target |
| Acetylcholine | Acetylcholinesterase | enzyme |
| Acetylcholine | Cholinesterase | enzyme |
| Arecoline | Muscarinic acetylcholine receptor M1 | target |
| Arecoline | Muscarinic acetylcholine receptor M3 | target |
| Huperzine A | Acetylcholinesterase | target |
| Lobeline | Neuronal acetylcholine receptor subunit alpha-9 | target |
| Lobeline | Neuronal acetylcholine receptor subunit alpha-10 | target |
| Lobeline | Neuronal acetylcholine receptor subunit alpha-7 | target |
| Lobeline | Synaptic vesicular amine transporter | target |
| GTS-21 | Neuronal acetylcholine receptor subunit alpha-7 | target |
| GTS-21 | Cytochrome P450 1A2 | enzyme |
| GTS-21 | Cytochrome P450 2E1 | enzyme |
| Fesoterodine | Muscarinic acetylcholine receptor M1 | target |
| Fesoterodine | Muscarinic acetylcholine receptor M3 | target |
| Fesoterodine | Cytochrome P450 3A4 | enzyme |
| Fesoterodine | Muscarinic acetylcholine receptor M2 | target |
| Fesoterodine | Muscarinic acetylcholine receptor M4 | target |
| Fesoterodine | Muscarinic acetylcholine receptor M5 | target |
| Fesoterodine | Cytochrome P450 2D6 | enzyme |
| Fesoterodine | P-glycoprotein 1 | transporter |
| Methacholine | Muscarinic acetylcholine receptor M3 | target |
| Methacholine | Muscarinic acetylcholine receptor M2 | target |
| Methacholine | Muscarinic acetylcholine receptor M1 | target |
| Methacholine | Muscarinic acetylcholine receptor M4 | target |
| Methacholine | Muscarinic acetylcholine receptor M5 | target |
| Methacholine | Solute carrier family 22 member 5 | transporter |
| Epibatidine | CHRNA7-FAM7A fusion protein | target |
| Epibatidine | Neuronal acetylcholine receptor subunit alpha-7 | target |
| Epibatidine | Neuronal acetylcholine receptor subunit beta-2 | target |
| Epibatidine | Neuronal acetylcholine receptor subunit alpha-2 | target |
| Epibatidine | Neuronal acetylcholine receptor subunit alpha-3 | target |
| Epibatidine | Neuronal acetylcholine receptor subunit alpha-4 | target |
| Epibatidine | Neuronal acetylcholine receptor subunit beta-4 | target |
| Hexamethonium | Neuronal acetylcholine receptor subunit alpha-2 | target |
| Hexamethonium | Dihydroorotate dehydrogenase (quinone), mitochondrial | target |
| Benactyzine | Muscarinic acetylcholine receptor M5 | target |
| Butylscopolamine | Muscarinic acetylcholine receptor M3 | target |
| Butylscopolamine | Muscarinic acetylcholine receptor M2 | target |
| Butylscopolamine | Muscarinic acetylcholine receptor M5 | target |
| Dichlorvos | Serum albumin | carrier |
| Dichlorvos | Serotransferrin | target |
| Dichlorvos | Cholinesterase | target |
| Imidacloprid | CHRNA7-FAM7A fusion protein | target |
| Propiverine | Muscarinic acetylcholine receptor M1 | target |
| Propiverine | Muscarinic acetylcholine receptor M2 | target |
| Propiverine | Muscarinic acetylcholine receptor M3 | target |
| Propiverine | Muscarinic acetylcholine receptor M4 | target |
| Propiverine | Muscarinic acetylcholine receptor M5 | target |
| Propiverine | Voltage-dependent L-type calcium channel subunit alpha-1C | target |
| Propiverine | Alpha-1A adrenergic receptor | target |
| Propiverine | Cytochrome P450 3A4 | enzyme |
| Propiverine | Dimethylaniline monooxygenase [N-oxide-forming] 1 | enzyme |
| Propiverine | Dimethylaniline monooxygenase [N-oxide-forming] 3 | enzyme |
| Methanesulfonyl Fluoride | Acetylcholinesterase | target |
| Paraoxon | Carbonic anhydrase 1 | target |
| Paraoxon | Cannabinoid receptor 1 | target |
| Paraoxon | Acetylcholinesterase | target |
| Paraoxon | Carbonic anhydrase 2 | target |
| Otilonium | Cytochrome P450 3A4 | enzyme |
| Emepronium | Muscarinic acetylcholine receptor M5 | target |
| Alcuronium | Neuronal acetylcholine receptor subunit alpha-7 | target |
| Obidoxime | Acetylcholinesterase | target |
| Mivacurium | Neuronal acetylcholine receptor subunit alpha-2 | target |
| Mivacurium | Muscarinic acetylcholine receptor M2 | target |
| Mivacurium | Muscarinic acetylcholine receptor M3 | target |
| Mivacurium | Cholinesterase | target |
| Mivacurium | Cholinesterase | enzyme |
| Azatadine | Histamine H1 receptor | target |
| Meclizine | Histamine H1 receptor | target |
| Meclizine | Nuclear receptor subfamily 1 group I member 3 | target |
| Meclizine | Cytochrome P450 2D6 | enzyme |
| Meclizine | Serum albumin | carrier |
| Hexafluronium | Cholinesterase | target |
| Phenserine | Acetylcholinesterase | target |
| Phenserine | Cholinesterase | target |
| Phenserine | Amyloid beta A4 protein | target |
| NGX267 | Muscarinic acetylcholine receptor M1 | target |
| TAK-071 | Muscarinic acetylcholine receptor M1 | target |